76
|
Binet R, Fonti C, Ythier D, Larrieu D, Brambilla E, Brambilla C, Pedeux R. Régulation et fonction de la protéine WNT16B dans la sénescence cellulaire. Rev Mal Respir 2008. [DOI: 10.1016/s0761-8425(08)75036-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
77
|
Levallet G, Bergot E, Defraipont F, Creveuil C, Antoine M, Brambilla E, Beau-Faller M, Mounawar M, Favrot M, Hainaut P, Milleron B, Zalcman G. Étude des marqueurs immunohistochimiques (IHC) et moléculaires de résistance à la chimiothérapie péri-opératoire : protocole national Bio-IFCT 0002. Rev Mal Respir 2008. [DOI: 10.1016/s0761-8425(08)75035-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
78
|
De Seranno S, Ryckewaert JJ, Brambilla E, Brambilla C, Meuwissen R. Rôle des cellules progénitrices dans l’initiation et la progression du cancer du poumon. Rev Mal Respir 2008. [DOI: 10.1016/s0761-8425(08)75018-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
79
|
Edmond V, Merdzhanova G, Van Den Broeck A, Brambilla C, Brambilla E, Gazzeri S, Eymin B. Contribution de la protéine SC35 aux fonctions prolifératives du facteur de transcription E2F1 au cours de la carcinogenèse pulmonaire. Rev Mal Respir 2008. [DOI: 10.1016/s0761-8425(08)75013-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
80
|
Van Den Broeck A, Eymin B, Khochbin S, Brambilla E, Gazzeri S. L’Histone Acétyltransférase Tip60 régule l’activité biologique du facteur de transcription E2F1. Rev Mal Respir 2008. [DOI: 10.1016/s0761-8425(08)75012-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
81
|
Merdzhanova G, Edmond V, De Seranno S, Van den Broeck A, Corcos L, Brambilla C, Brambilla E, Gazzeri S, Eymin B. E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35. Cell Death Differ 2008; 15:1815-23. [DOI: 10.1038/cdd.2008.135] [Citation(s) in RCA: 72] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
|
82
|
Lantuéjoul S, Brambilla E. [What's new in the 2004 WHO classification of the lung tumors?]. REVUE DE PNEUMOLOGIE CLINIQUE 2008; 64:187-194. [PMID: 19019287 DOI: 10.1016/j.pneumo.2008.07.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
|
83
|
Raynaud CM, Jang SJ, Nuciforo P, Lantuejoul S, Brambilla E, Mounier N, Olaussen KA, André F, Morat L, Sabatier L, Soria JC. Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions. Ann Oncol 2008; 19:1875-81. [PMID: 18641004 DOI: 10.1093/annonc/mdn405] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND A relation between telomere attrition in early carcinogenesis and activation of DNA damage response (DDR) has been proposed. We explored telomere length and its link with DDR in colorectal multistep carcinogenesis. PATIENTS AND METHODS We studied normal mucosa, low-grade dysplasia (LGD) and high-grade dysplasia (HGD) and invasive carcinoma (IC) in matched human colon specimens by evaluating p-ataxia telangiectasia mutated (ATM), p-checkpoint kinase 2 (Chk2), c-H2AX, TRF1 and TRF2 expressions by immunohistochemistry. FISH was used to assess telomere length. RESULTS Telomeres shortened significantly from normal (N) to LGD and HGD (P < 0.0001; P = 0.012), then increased in length in IC (P = 0.006). TRF1 and TRF2 expressions were diminished from N to LGD and HGD (P = 0.004, P < 0.0001, ns) and were reexpressed at the invasive stage (P = 0.053 and P = 0.046). Phosphorylated ATM, Chk2 and H2AX appeared already in LGD (respectively, P = 0.001, P = 0.002 and P = 0.02). Their expression decreased from HGD to IC (respectively, P = 0.03, P = 0.02 and P = 0.37). These activating phosphorylations were inversely correlated with telomere length and TRF1/2 expression. CONCLUSION In a model of colon multistep carcinogenesis, our data indicate that telomeric length and protein expression levels are inversely correlated with the activation of the DDR pathway.
Collapse
|
84
|
Strohmenger L, Brambilla E. The use of fluoride varnishes in the prevention of dental caries: a short review. Oral Dis 2008. [DOI: 10.1034/j.1601-0825.2001.70202.x] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
85
|
Van Den Broeck A, Eymin B, Moro-Sibilot D, Lantuejoul S, Brambilla C, Brambilla E, Gazzeri S. Aberrant pattern of histone H4 modification in human lung carcinoma. EJC Suppl 2008. [DOI: 10.1016/s1359-6349(08)71770-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
86
|
Ma X, Brambilla E, Soria J, Dunant A, Vataire A, Hainaut P, the IALT-Bio study group. Impact of TP53 and KRAS mutations on cisplatin-based adjuvant chemotherapy in non-small-cell lung cancer. EJC Suppl 2008. [DOI: 10.1016/s1359-6349(08)71573-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
87
|
Wislez M, Antoine M, Poulot V, Baudrin L, Beau-Faller M, Morere J, Brambilla E, Lebitasy M, Coulet F, Cadranel J. IFCT0401-bio phase II trial: Gefitinib administered as 1st-line in non-resectable adenocarcinoma with bronchioloalveolar carcinoma features (ADC-BAC)—Predictive biomarkers of efficacy and survival. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.8071] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
88
|
Righini CA, Faure C, Lantuejoul S, Chahine K, Soriano E, Brambilla E, Bolla M, Reyt E. Course and prognosis of basaloid squamous cell carcinoma (BSCC) of the head and neck: A case-control study of 62 patients. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.17002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
89
|
Moro-Sibilot D, Lantuejoul S, Diab S, Moulai N, Aubert A, Timsit JF, Brambilla C, Brichon PY, Brambilla E. Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis. Eur Respir J 2008; 31:854-9. [DOI: 10.1183/09031936.00058507] [Citation(s) in RCA: 66] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
90
|
Butti E, Bergami A, Recchia A, Brambilla E, Del Carro U, Amadio S, Cattalini A, Esposito M, Stornaiuolo A, Comi G, Pluchino S, Mavilio F, Martino G, Furlan R. IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis. Gene Ther 2008; 15:504-15. [PMID: 18239607 DOI: 10.1038/gt.2008.10] [Citation(s) in RCA: 76] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Central nervous system (CNS) delivery of anti-inflammatory cytokines, such as interleukin 4 (IL4), holds promise as treatment for multiple sclerosis (MS). We have previously shown that short-term herpes simplex virus type 1-mediated IL4 gene therapy is able to inhibit experimental autoimmune encephalomyelitis (EAE), an animal model of MS, in mice and non-human primates. Here, we show that a single administration of an IL4-expressing helper-dependent adenoviral vector (HD-Ad) into the cerebrospinal fluid (CSF) circulation of immunocompetent mice allows persistent transduction of neuroepithelial cells and long-term (up to 5 months) CNS transgene expression without toxicity. Mice affected by chronic and relapsing EAE display clinical and neurophysiological recovery from the disease once injected with the IL4-expressing HD-Ad vector. The therapeutic effect is due to the ability of IL4 to increase, in inflamed CNS areas, chemokines (CCL1, CCL17 and CCL22) capable of recruiting regulatory T cells (CD4+CD69-CD25+Foxp3+) with suppressant functions. CSF delivery of HD-Ad vectors expressing anti-inflammatory molecules might represent a valuable therapeutic option for CNS inflammatory disorders.
Collapse
|
91
|
Lantuejoul S, Moulai N, Quetant S, Brichon PY, Brambilla C, Brambilla E, Ferretti GR. Unusual cystic presentation of pulmonary nodular amyloidosis associated with MALT-type lymphoma. Eur Respir J 2007; 30:589-92. [PMID: 17766635 DOI: 10.1183/09031936.00136605] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
The case reported herein consists of nodular pulmonary amyloidosis presenting with unusual cystic radiological features which reveal a pulmonary localisation of an extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). The present case is the first to report a radiological presentation of nodular pulmonary amyloidosis in the absence of Sjögren's syndrome. Although transthoracic fine-needle biopsy was helpful for the diagnostic of amyloidosis, final diagnosis of associated MALT-type lymphoma required an open lung biopsy. This emphasises the importance of performing surgical investigations in pulmonary nodular amyloidosis in order to depict the presence of underlying lung tumours or lymphoproliferative disorders.
Collapse
MESH Headings
- Amyloidosis/diagnostic imaging
- Amyloidosis/pathology
- Antibodies, Monoclonal/therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents/therapeutic use
- Bone Marrow Neoplasms/diagnostic imaging
- Bone Marrow Neoplasms/drug therapy
- Bone Marrow Neoplasms/pathology
- Bone Marrow Transplantation
- Bronchi/pathology
- Cysts/diagnostic imaging
- Cysts/pathology
- Female
- Helicobacter Infections/diagnostic imaging
- Helicobacter Infections/pathology
- Helicobacter pylori
- Humans
- Lung/pathology
- Lung Diseases/diagnostic imaging
- Lung Diseases/pathology
- Lung Neoplasms/diagnostic imaging
- Lung Neoplasms/drug therapy
- Lung Neoplasms/pathology
- Lymphocytes/pathology
- Lymphoma, B-Cell, Marginal Zone/diagnostic imaging
- Lymphoma, B-Cell, Marginal Zone/drug therapy
- Lymphoma, B-Cell, Marginal Zone/pathology
- Middle Aged
- Neoplasm Invasiveness
- Neoplasm Staging
- Paraneoplastic Syndromes/diagnostic imaging
- Paraneoplastic Syndromes/pathology
- Rituximab
- Solitary Pulmonary Nodule/diagnostic imaging
- Solitary Pulmonary Nodule/pathology
- Stomach Neoplasms/diagnostic imaging
- Stomach Neoplasms/drug therapy
- Stomach Neoplasms/pathology
- Tomography, X-Ray Computed
Collapse
|
92
|
Salon C, Brambilla E, Brambilla C, Lantuejoul S, Gazzeri S, Eymin B. Altered pattern of Cul-1 protein expression and neddylation in human lung tumours: relationships with CAND1 and cyclin E protein levels. J Pathol 2007; 213:303-10. [PMID: 17823919 DOI: 10.1002/path.2223] [Citation(s) in RCA: 53] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
The Cul-1 protein is the scaffold element of SCF complexes that are involved in the proteasomal degradation of numerous proteins regulating cell cycle progression. Owing to this central role in cell growth control, aberrant expression of the components of SCF is thought to play a role during tumourigenesis. Nothing is known about Cul-1 expression in human tumours. In this study, we have analysed its status in a series of 128 human lung carcinomas, comprising 50 non-small cell lung cancers (NSCLCs; 29 squamous cell carcinomas and 21 adenocarcinomas) and 78 neuroendocrine (NE) lung tumours (24 typical and atypical carcinoids, 19 large cell NE carcinomas and 35 small cell lung carcinomas), using immunohistochemistry. We report for the first time an altered pattern of Cul-1 expression in human tumours; indeed, we show that Cul-1 expression is up-regulated in 40% (51/128) of all lung tumours as compared to normal lung tissues, including 34% (17/50), 75% (18/24) and 30% (16/54) of NSCLCs, carcinoids and high grade neuroendocrine lung carcinomas, respectively. Furthermore, we demonstrate that high levels of Cul-1 protein are associated with a low KI67 proliferative index (p = 0.005) and with a decrease in the cyclin E oncoprotein (p = 0.0003), one of the major targets of SCF complexes. These data suggest that up-regulation of Cul-1 could protect cells from hyperproliferative signals through cyclin E down-regulation. Cul-1 is modified by neddylation, a post-translational modification that grafts ubiquitin-like Nedd8/Rub1 residues and controls Cul-1 activity. We also provide evidence that neddylated forms of Cul-1 are specifically expressed in high-grade NE lung tumours and are associated with down-regulation of the Cul-1 inhibitor CAND1 (p = 0.03) and a high level of cyclin E (p = 0.0002). These data support the notion that alterations in the Cul-1 neddylation/deneddylation pathway could contribute to the development of these highly aggressive lung tumours.
Collapse
|
93
|
De Serrano S, Ryckewaert J, Brambilla E, Brambilla C, Meuwissen R. 055 Role of cancer stem cells in the onset, progression and maintenance of lung cancer. Rev Mal Respir 2007. [DOI: 10.1016/s0761-8425(07)74346-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
94
|
Merdzhanova G, Edmond V, Betton P, Brambilla C, Brambilla E, Gazzeri S, Eymin B. 042 Identification du facteur d’épissage SC35 comme une nouvelle cible de E2F1. Rev Mal Respir 2007. [DOI: 10.1016/s0761-8425(07)74333-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
95
|
Salon C, Brambilla E, Veyrenc S, Claraz C, Brambilla C, Lantuejoul S, Gazzeri S, Eymin B. 045 Altered pattern of Cul-1 protein expression and neddylation in human lung tumors : relationships with CAND1 and cyclin E protein levels. Rev Mal Respir 2007. [DOI: 10.1016/s0761-8425(07)74336-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
96
|
Nissou D, Ythier D, Binet R, Larrieu D, Escales L, Brambilla C, Brambilla E, Pedeux R. 039 Involvement of the tumor suppressor ING2 gene in lung cancer. Rev Mal Respir 2007. [DOI: 10.1016/s0761-8425(07)74330-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
97
|
Brambilla E. Apport des ARNs et micro-ARNs dans la classification des carcinomes broncho-pulmonaires. Ann Pathol 2007. [DOI: 10.1016/s0242-6498(07)92860-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
98
|
Edmond V, Merdzhanova G, Betton P, Van Den Broeck A, Brambilla C, Brambilla E, Gazzeri S, Eymin B. 043 Contribution de la protéine SC35 aux fonctions prolifératives du facteur de transcription E2F1 au cours de la carcinogénèse pulmonaire. Rev Mal Respir 2007. [DOI: 10.1016/s0761-8425(07)74334-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
99
|
Binet R, Ythier D, Larrieu D, Nissou D, Brambilla C, Brambilla E, Pedeux R. 038 WNT16, un nouveau marqueur de la sénescence cellulaire : régulation et fonctions. Rev Mal Respir 2007. [DOI: 10.1016/s0761-8425(07)74329-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
100
|
Larrieu D, Ythier D, Binet R, Nissou D, Brambilla E, Pedeux R. 040 Identification de nouveaux partenaires protéiques pour le gène « candidat » suppresseur de tumeur ING2. Rev Mal Respir 2007. [DOI: 10.1016/s0761-8425(07)74331-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|